Busulphane and treosulphane in therapy of pediatric solid tumors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00085319" target="_blank" >RIV/00216224:14110/15:00085319 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Busulphane and treosulphane in therapy of pediatric solid tumors
Original language description
Busulfan and treosulfan are strong alkylating agents with significant antitumor myeloablative and immunosupresive potential. Both these preparations are integral consolidation treatment of high-risk pediatric solid tumors, particularly neuroblastoma (NBL) and Ewing's sarcoma (ES) either at the time of primary therapy as well as in the treatment of relapse of these diseases.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů